Apparent diffusion coefficient radiomics for differentiating benign and malignant PI-RADS 3–5 prostate lesions: external validation

Bray F, Laversanne M, Sung H et al (2022) Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 74(3):229–263. https://doi.org/10.3322/caac.21834

Article  Google Scholar 

Czerw A, Deptała A, Głowacka M et al (2025) Prostate cancer-research advances in early detection. J Clin Med. https://doi.org/10.3390/jcm14093067

Article  PubMed  PubMed Central  Google Scholar 

Leenen RCA, Venderbos LDF, Helleman J et al (2025) Prostate cancer early detection in the European Union and UK. Eur Urol 87(3):326–339. https://doi.org/10.1016/j.eururo.2024.07.019

Article  PubMed  Google Scholar 

Matsukawa A, Yanagisawa T, Bekku K et al (2024) Comparing the performance of digital rectal examination and prostate-specific antigen as a screening test for prostate cancer: a systematic review and meta-analysis. Eur Urol Oncol 7(4):697–704. https://doi.org/10.1016/j.euo.2023.12.005

Article  PubMed  Google Scholar 

Serdà-Ferrer BC, Sanvisens A, Fuentes-Raspall R et al (2023) Significantly reduced incidence and improved survival from prostate cancer over 25 years. BMC Public Health 23(1):2552. https://doi.org/10.1186/s12889-023-17440-7

Article  PubMed  PubMed Central  Google Scholar 

Jiao J, Ma S, Wu P et al (2025) Transrectal Ultrasound-guided prostate biopsy with and without PSMA-PET-targeted prostate biopsy for prostate cancer diagnosis. Clin Cancer Res 31(20):4278–4287. https://doi.org/10.1158/1078-0432.Ccr-25-0320

Article  CAS  PubMed  PubMed Central  Google Scholar 

Fazekas T, Shim SR, Basile G et al (2024) Magnetic resonance imaging in prostate cancer screening: a systematic review and meta-analysis. JAMA Oncol 10(6):745–754. https://doi.org/10.1001/jamaoncol.2024.0734

Article  PubMed  PubMed Central  Google Scholar 

Stabile A, Giganti F, Rosenkrantz AB et al (2020) Multiparametric MRI for prostate cancer diagnosis: current status and future directions. Nat Rev Urol 17(1):41–61. https://doi.org/10.1038/s41585-019-0212-4

Article  PubMed  Google Scholar 

Asif A, Nathan A, Ng A et al (2023) Comparing biparametric to multiparametric MRI in the diagnosis of clinically significant prostate cancer in biopsy-naive men (PRIME): a prospective, international, multicentre, non-inferiority within-patient, diagnostic yield trial protocol. BMJ Open 13(4):e070280. https://doi.org/10.1136/bmjopen-2022-070280

Article  PubMed  PubMed Central  Google Scholar 

De Perrot T, Sadjo Zoua C, Glessgen CG et al (2022) Diffusion-weighted MRI in the genitourinary system. J Clin Med. https://doi.org/10.3390/jcm11071921

Article  PubMed  PubMed Central  Google Scholar 

Agrotis G, Pooch E, Abdelatty M et al (2025) Diagnostic performance of ADC and ADCratio in MRI-based prostate cancer assessment: a systematic review and meta-analysis. Eur Radiol 35(1):404–416. https://doi.org/10.1007/s00330-024-10890-6

Article  PubMed  Google Scholar 

Sushentsev N, Rundo L, Blyuss O, Gnanapragasam VJ, Sala E, Barrett T (2021) MRI-derived radiomics model for baseline prediction of prostate cancer progression on active surveillance. Sci Rep 11(1):12917. https://doi.org/10.1038/s41598-021-92341-6

Article  CAS  PubMed  PubMed Central  Google Scholar 

Han C, Ma S, Liu X et al (2021) Radiomics models based on apparent diffusion coefficient maps for the prediction of high-grade prostate cancer at radical prostatectomy: comparison with preoperative biopsy. J Magn Reson Imaging 54(6):1892–1901. https://doi.org/10.1002/jmri.27565

Article  PubMed  Google Scholar 

Bleker J, Kwee TC, Yakar D (2022) Quality of multicenter studies using MRI radiomics for diagnosing clinically significant prostate cancer: a systematic review. Life (Basel). https://doi.org/10.3390/life12070946

Article  PubMed  PubMed Central  Google Scholar 

Corradini D, Brizi L, Gaudiano C et al (2021) Challenges in the use of artificial intelligence for prostate cancer diagnosis from multiparametric imaging data. Cancers (Basel). https://doi.org/10.3390/cancers13163944

Article  PubMed  PubMed Central  Google Scholar 

Margolis DJA, Chatterjee A, deSouza NM et al (2025) Quantitative prostate MRI, from the AJR special series on quantitative imaging. AJR Am J Roentgenol 225(2):e2431715. https://doi.org/10.2214/ajr.24.31715

Article  PubMed  Google Scholar 

Chen X, Wang H, Xia Y, Shi F, He L, Liu E (2024) The relationship between contrast-enhanced computed tomography radiomics features and mitosis karyorrhexis index in neuroblastoma. Discov Oncol 15(1):201. https://doi.org/10.1007/s12672-024-01067-0

Article  CAS  PubMed  PubMed Central  Google Scholar 

Zwanenburg A, Leger S, Vallières M, Löck S. Image biomarker standardisation initiative. arXiv preprint arXiv. 2016. http://arxiv.org/abs/1612.07003.

Zhao Y, Zhang L, Zhang S et al (2026) Machine learning-based MRI imaging for prostate cancer diagnosis: systematic review and meta-analysis. Prostate Cancer Prostatic Dis 29(1):159–166. https://doi.org/10.1038/s41391-025-00997-2

Article  PubMed  Google Scholar 

Ng A, Asif A, Agarwal R et al (2025) Biparametric vs multiparametric MRI for prostate cancer diagnosis: the PRIME diagnostic clinical trial. JAMA 334(13):1170–1179. https://doi.org/10.1001/jama.2025.13722

Article  PubMed  PubMed Central  Google Scholar 

Mylona E, Zaridis DI, Kalantzopoulos C et al (2024) Optimizing radiomics for prostate cancer diagnosis: feature selection strategies, machine learning classifiers, and MRI sequences. Insights Imaging 15(1):265. https://doi.org/10.1186/s13244-024-01783-9

Article  PubMed  PubMed Central  Google Scholar 

Oerther B, Nedelcu A, Engel H et al (2024) Update on PI-RADS version 2.1 diagnostic performance benchmarks for prostate MRI: systematic review and meta-analysis. Radiology 312(2):e233337. https://doi.org/10.1148/radiol.233337

Article  PubMed  Google Scholar 

Wang S, Kozarek J, Russell R et al (2024) Diagnostic performance of prostate-specific antigen density for detecting clinically significant prostate cancer in the era of magnetic resonance imaging: a systematic review and meta-analysis. Eur Urol Oncol 7(2):189–203. https://doi.org/10.1016/j.euo.2023.08.002

Article  CAS  PubMed  Google Scholar 

Zwanenburg A, Vallières M, Abdalah MA et al (2020) The image biomarker standardization initiative: standardized quantitative radiomics for high-throughput image-based phenotyping. Radiology 295(2):328–338. https://doi.org/10.1148/radiol.2020191145

Article  PubMed  PubMed Central  Google Scholar 

Salmanpour MR, Amiri S, Gharibi S et al (2026) Radiological and biological dictionary of radiomics features: addressing understandable AI issues in personalized prostate cancer, dictionary version PM1.0. J Imaging Informat Med 39(3):1929–1950. https://doi.org/10.1007/s10278-025-01585-5

Article  Google Scholar 

Cavallo AU, Stanzione A, Ponsiglione A et al (2025) Prostate cancer MRI methodological radiomics score: a EuSoMII radiomics auditing group initiative. Eur Radiol 35(3):1157–1165. https://doi.org/10.1007/s00330-024-11299-x

Article  PubMed  Google Scholar 

Yilmaz EC, Harmon SA, Law YM et al (2024) External validation of a previously developed deep learning-based prostate lesion detection algorithm on paired external and in-house biparametric MRI scans. Radiol Imaging Cancer 6(6):e240050. https://doi.org/10.1148/rycan.240050

Article  PubMed  PubMed Central  Google Scholar 

Patel HD, Remmers S, Ellis JL et al (2024) Comparison of magnetic resonance imaging-based risk calculators to predict prostate cancer risk. JAMA Netw Open 7(3):e241516. https://doi.org/10.1001/jamanetworkopen.2024.1516

Article  PubMed  PubMed Central  Google Scholar 

Bao J, Qiao X, Song Y et al (2024) Prediction of clinically significant prostate cancer using radiomics models in real-world clinical practice: a retrospective multicenter study. Insight Imaging 15(1):68. https://doi.org/10.1186/s13244-024-01631-w

Article  Google Scholar 

Comments (0)

No login
gif